NCT06528366View on ClinicalTrials.gov

Heart Failure With Reduced Ejection Fraction: Adjuvant Therapy With Neurostimulation and Chlorella Pyrenoidosa (HD-tDCS)

NAActive, not recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 26, 2023

Primary Completion Date

August 1, 2024

Study Completion Date

August 30, 2024

Conditions
Heart Failure, Reduced Ejection FractionVitamin B12 Deficiency
Interventions
DIETARY_SUPPLEMENT

Chlorella pyrenoidosa

Functional food, organically pressed into tablets (Registration with Anvisa/MS/Brazil: 6.7273.000)

DEVICE

High Definition Transcranial Direct Current Stimulation

Neuromodulation Technics, non invasive, target and safety

Trial Locations (1)

58051-900

Federal University of Paraíba, João Pessoa

All Listed Sponsors
collaborator

The City College of New York

OTHER

lead

Federal University of Paraíba

OTHER

NCT06528366 - Heart Failure With Reduced Ejection Fraction: Adjuvant Therapy With Neurostimulation and Chlorella Pyrenoidosa (HD-tDCS) | Biotech Hunter | Biotech Hunter